Publicacións nas que colabora con Francisco Carmona de la Torre (26)

2023

  1. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses

    Frontiers in Cellular and Infection Microbiology, Vol. 13

2022

  1. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

    Frontiers in Neurology, Vol. 13

  2. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

    Chest, Vol. 162, Núm. 5, pp. 1006-1016

  3. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299

2021

  1. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients

    Frontiers in Immunology, Vol. 12

  2. Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge

    Frontiers in Immunology, Vol. 12

  3. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

    Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946

  4. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

2020

  1. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: Preliminary experience from a series of 10 Spanish patients

    Thorax, Vol. 75, Núm. 12, pp. 1116-1118

  2. The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

    Trials, Vol. 21, Núm. 1

2019

  1. Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis

    Journal of Antimicrobial Chemotherapy

2018

  1. Cólera y otras infecciones del género Vibrio

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 50, pp. 2952-2962

  2. Fiebre en una paciente oncológica portadora de un dispositivo intravascular

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 49, pp. 2929-2930

  3. Infecciones del tracto urinario

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 51, pp. 3020-3030

  4. Paciente con fiebre, ictericia y dolor abdominal

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 51, pp. 3057-3058

  5. Protocolo de tratamiento de la bacteriemia asociada a catéter vascular central de larga duración

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 50, pp. 2972-2976

  6. Protocolo de tratamiento de la diarrea asociada a antibióticos

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 51, pp. 3031-3035

  7. Protocolo de tratamiento empírico de las infecciones urinarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 51, pp. 3041-3047

  8. Varón de 71 años portador de nefrostomías bilaterales y fiebre

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 50, pp. 2990-2991

2017

  1. Catheter-related bloodstream infections in patients with oncohaematological malignancies

    The Lancet Infectious Diseases